ANI Pharmaceuticals Inc (NASDAQ: ANIP). Significant positive changes in fundamentals have recently occurred: the consensus estimate for December, 2025 increased significantly, the stock’s power rating rose above 70, and the consensus estimate for December, 2026 increased significantly.
ANI Pharmaceuticals Inc (NASDAQ: ANIP). Significant positive changes in investment behavior have recently occurred: positive upside/downside volume developed.
In light of these very positive signals we are reviewing our current Overall Rating of A. We would continue to view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
ANI Pharmaceuticals has a current Value Trend Rating of A (Highest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. ANI Pharmaceuticals has a slightly positive Appreciation Score of 61 and a good Power Rating of 79, and the Highest Value Trend Rating results.
Recent Price Action
ANI Pharmaceuticals Inc (NASDAQ: ANIP) stock declined slightly by -0.7% on 9/5/25. The stock closed at $95.35. However, below average trading volume at 82% of normal accompanied the decline. The stock has risen 3.8% during the last week and has been exceptionally strong relative to the market over the last nine months.
Be the first to comment